UAECell-19

N/A

Report date: 2025/07/30 20:01:17

Base Information

Drug NameUAECell-19

Drug Alias Nameutologous Non-Hematopoietic Peripheral Blood Stem CellsNHPBSCUAECell-19

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Peripheral blood-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Arab Emirates

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAbu Dhabi Stem Cells Center

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAbu Dhabi Stem Cells Center

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A